11:12 AM EDT, 05/13/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts kicked off the week higher in Monday morning, rising 0.62% to 1,421.16 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by hotel booking site trivago (TRVG) and biotech firm Evaxion Biotech ( EVAX ) , which rose 3.5% and 2.7% respectively. They were followed by telecommunications company Nokia ( NOK ) and biopharmaceutical company Grifols ( GRFS ) , which increased 2.2% each.

The decliners from continental Europe were led by biopharmaceutical company Cellectis ( CLLS ) and semiconductor company Sequans Communications ( SQNS ) , which fell 3.6% and 2.4% respectively. They were followed by biopharmaceutical company Genfit ( GNFT ) and medical device maker EDAP TMS ( EDAP ) , which dropped 1.9% and 1.3% respectively.

From the UK and Ireland, the gainers were led by pharmaceutical firms Avadel Pharmaceuticals ( AVDL ) and Amarin ( AMRN ) , which rose 4.8% and 4.3% respectively. They were followed by biopharmaceutical company Adaptimmune Therapeutics ( ADAP ) and pharmaceutical company Silence Therapeutics ( SLN ) , which were up 3.6% and 2.8% respectively.

The decliners from the UK and Ireland were led by biotech firm Autolus Therapeutics ( AUTL ) and biopharmaceutical company TC Biopharm ( TCBP ) , which lost 4.5% and 4.3% respectively. They were followed by educational publisher Pearson (PSO), which was down 0.8%.